Johnson & Johnson (J&J) is set to acquire partner Verb Surgical for $3.4bn, with an additional $2.35bn available to the surgical robotics firm in predetermined milestone payments. As part of the deal, surgical robotics pioneer and Auris founder Dr Fred Moll will join J&J. The purchase is one of several forays the multinational has made in the surgical robotics sector, including last year's acquisition of Orthotaxy, and the creation of Auris Health, a joint venture with Alphabet's Verily.
Johnson & Johnson (J&J) is set to acquire partner Auris Health for $3.4bn, with an additional $2.35bn available to the surgical robotics firm in predetermined milestone payments. As part of the deal, surgical robotics pioneer and Auris founder Dr Fred Moll will join J&J. The purchase is one of several forays the multinational has made in the surgical robotics sector, including last year's acquisition of Orthotaxy, and the creation of Verb Surgical, a joint venture with Alphabet's Verily.